Patients with advanced cancer who also had cardiac defibrillators were more likely than those without these implants to ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

In one analysis, 16% of men with no suspicious lesions on MRI had clinically significant prostate cancer identified after ...

Researchers conducted a post hoc, retrospective, cross-sectional analysis of 182 patients with recurrent prostate cancer ...

A study co-led by UCLA scientists has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal ...

A TRANSPLANT recipient has died of cancer after contracting the illness from his organ donor. The unnamed patient, 69, from Arizona underwent an organ transplant to treat his liver ...

The results were promising. Men on the omega-3-rich diet experienced a 15% decrease in the Ki-67 index, while the control ...

Movember aims to raise awareness of men’s health for the month of November. Prostate cancer is the most common (non-cutaneous ...

"I would say to anyone, if standard treatment isn’t working for you, then ask about clinical trials. I’m so glad I did." ...

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.

Roughly 70 percent of patients are diagnosed with prostate cancers in the early stages of the disease, before surgery, ...